Announcements Trials
Browse Landscape

Status

Completed 176Recruiting 41Unknown 40Terminated 31Active not recruiting 13Not yet recruiting 8Withdrawn 7No longer available 5Suspended 2Enrolling by invitation 1Available 1Approved for marketing 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Expanded_access 5

Sponsor

Cancer Type

Sarcoma 5Gastrointestinal 5CNS 1

Conditions

Pancreatic Neoplasms 5Gastrointestinal Stromal Tumors 5Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Liver Neoplasms 4Ovarian Neoplasms 2Melanoma 2Cholangiocarcinoma 2Wilms Tumor 1Uveal Melanoma 1Uterine Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Prostatic Neoplasms 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Meningeal Neoplasms 1Medulloblastoma 1Liver Diseases 1Liver Cirrhosis 1Klatskin Tumor 1Hepatoblastoma 1Hepatitis D 1Hepatitis B 1

Interventions

regorafenib 2avapritinib 1Imatinib Mesylate 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
No longer available × Gastrointestinal Stromal Tumors × Gastrointestinal × Clear all
NCT03493152 2025-05-28

Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)

The University of Texas Health Science Center at San Antonio

No longer available
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04714086 2024-10-24

Expanded Access Program for Avapritinib

Blueprint Medicines Corporation

No longer available
CNSGastrointestinalSarcoma

Glioma, Gastrointestinal Stromal Tumors

NCT01689376 2016-08-16

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)

Bayer

No longer available
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01613053 2015-04-24

MACS2226

Novartis

No longer available
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01646593 2014-12-15

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

Bayer

No longer available
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡